EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Systematic Review and Meta-Analysis: Prevalence of Meibomian Gland Dysfunction Among Adults Aged 40 Years and Older

Balzhan Karimberdiyeva, Zhanat Sadibekova, Aizhan Raushanova, Indira Karibayeva iD, Nuray Yerbol iD, Zinat Abdrakhmanova

Journal of Clinical Medicine · 16.04.2026 · 15 (8) · 3034

DOI: 10.3390/jcm15083034 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 16.04.2026. Verfasst von Balzhan Karimberdiyeva und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Kazakhstan Medical University "KSPH", Almaty 050060, Kazakhstan. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Meibomian gland dysfunction (MGD) is a major contributor to evaporative dry eye disease, yet reported prevalence estimates vary widely across studies, largely due to differences in diagnostic criteria, study populations, and settings. We conducted a systematic review and meta-analysis to synthesize available evidence on the prevalence of MGD in adults aged ≥40 years and to examine sources of heterogeneity across studies.

Methods

We systematically searched PubMed, Web of Science, Scopus, and Google Scholar from inception to November 2025 for observational studies reporting the prevalence of MGD in adult populations. Random-effects meta-analysis of proportions was performed. Subgroup analyses were conducted by study setting and diagnostic approach. Between-study heterogeneity was quantified using the I2 statistic.

Results

Eight observational studies from Singapore, Spain, Russia, Iran, China, Japan, and New Zealand, comprising 20,518 participants, met inclusion criteria. Reported prevalence of MGD varied substantially across studies. The pooled prevalence estimate was 87.08% (95% CI: 65.32–96.02%); however, heterogeneity was extreme (I2 > 99%), indicating substantial variability across populations and study methods. This pooled estimate should be interpreted with caution and not as a single representative global prevalence. Studies using clinical signs alone tended to report higher prevalence than those incorporating both signs and symptoms. Differences in study setting and diagnostic definitions accounted for a significant proportion of heterogeneity.

Conclusions

MGD appears to be commonly detected in adults aged ≥40 years; however, prevalence estimates vary markedly depending on diagnostic criteria and study design. Given the extreme heterogeneity, pooled prevalence estimates should be interpreted with caution and not as a single global prevalence value. Standardized diagnostic definitions and population-based studies using harmonized methodologies are needed to generate more comparable and clinically interpretable estimates of MGD burden.

Schlagwörter

Stichwörter der Autor:innen

dry eye diseaseepidemiologymeibomian gland dysfunctionmeta-analysisolder adultsprevalence

Autor:innen und Institutionen

  • Department of Public Health, Kazakhstan Medical University "KSPH", Almaty 050060, Kazakhstan.
  • Department of Public Health and Healthcare, South Kazakhstan Medical Academy, Al-Farabi Square 1/1, Shymkent 160019, Kazakhstan.
  • Department of Epidemiology, Biostatistics and Evidence-Based Medicine, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.
  • Department of Health Policy and Community Health, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, GA 30460, USA.
  • Department of Research Management, JSC Research Institute of Cardiology and Internal Diseases, Almaty 050012, Kazakhstan.
  • Department of Public Health, Kazakh-Russian Medical University, Almaty 050000, Kazakhstan.

ORCID-Profile: Indira Karibayeva, Nuray Yerbol

Zitieren

APA

Karimberdiyeva, B., Sadibekova, Z., Raushanova, A., Karibayeva, I., Yerbol, N., & Abdrakhmanova, Z. (2026). Systematic Review and Meta-Analysis: Prevalence of Meibomian Gland Dysfunction Among Adults Aged 40 Years and Older. Journal of Clinical Medicine, 15(8), 3034. https://doi.org/10.3390/jcm15083034

Vancouver

Karimberdiyeva B, Sadibekova Z, Raushanova A, Karibayeva I, Yerbol N, Abdrakhmanova Z. Systematic Review and Meta-Analysis: Prevalence of Meibomian Gland Dysfunction Among Adults Aged 40 Years and Older. Journal of Clinical Medicine. 2026;15(8):3034. doi:10.3390/jcm15083034

BibTeX
@article{Karimberdiyeva2026,
  author = {Karimberdiyeva, Balzhan and Sadibekova, Zhanat and Raushanova, Aizhan and Karibayeva, Indira and Yerbol, Nuray and Abdrakhmanova, Zinat},
  title = {Systematic Review and Meta-Analysis: Prevalence of Meibomian Gland Dysfunction Among Adults Aged 40 Years and Older},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {8},
  pages = {3034},
  doi = {10.3390/jcm15083034}
}
Kostenlos starten →